Chimäre Antigenrezeptoren zum Targeting von Cd-19
EP4714968
25. März 2026
Anmelder: The United States of America, as represented by the Secretary, Department of Health and Human Services 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4714968
- Anmeldetag
- 1. Juni 2015
- Veröffentlichung
- 25. März 2026
- Rechtsraum
- EP
- IPC
- C07K14/725(UNIV TEXAS et al.)(US HEALTH et al.)(CAMPANA DARIO et al.)(KING DAVID JOHN et al.)(NOVARTIS AG et al.)NUC. ACID. RES., vol. 28, 2000
Abstract
The invention is directed to a chimeric antigen receptor (CAR) directed against CD19, which comprises an amino acid sequence of any one of SEQ ID NO: 1- SEQ ID NO: 13. The invention also provides T-cells expressing the CAR and methods for destroying malignant B-cells.
Anmelder
- Firma
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Land
- 🇺🇸 USA
🇺🇸
United States Department of Health and Human Services
US-Bundesministerium, das über seine Behörden (u.a. NIH) medizinische Forschung fördert und daraus resultierende Patente im Namen der US-Regierung hält.
391 Patente in unserer Datenbank
Vertreten von
-
Maiwald GmbH
Maiwald GmbH · München